Evaluation of depression, anxiety and quality of life in hepatitis C patients who treated with direct acting antiviral agents

Kesen O., Kani H., Yanartaş Ö., Aykut U., Gök B., Gündüz F., ...More

TURKISH JOURNAL OF GASTROENTEROLOGY, vol.30, no.9, pp.801-806, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 30 Issue: 9
  • Publication Date: 2019
  • Doi Number: 10.5152/tjg.2019.18679
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.801-806
  • Keywords: Anxiety, depression, direct acting antiviral agent, hepatitis C, quality of life, RIBAVIRIN, INTERFERON-ALPHA-2B, IMPACT
  • Recep Tayyip Erdoğan University Affiliated: No


Background/Aims: Hepatitis C virus (HCV) infection is known to impair the quality of life (QoL). Increased levels of anxiety and depression have been found in HCV infection with a prevalence of 28% and 33%, respectively. Our aim was to investigate depression, anxiety, and QoL of chronic hepatitis C (CHC) patients before and after treatment with a direct-acting antiviral agent (DAAA).